Quest Diagnostics introduced its AI Companion on March 2, 2026, a chat‑based feature that analyzes up to five years of a patient’s laboratory data to deliver personalized explanations and health‑risk insights. The companion is embedded in the MyQuest mobile app and web portal, allowing users to ask questions about their results and receive instant, easy‑to‑understand answers without leaving the secure, HIPAA‑compliant platform.
Powered by Google Cloud’s Gemini models, the AI Companion operates entirely within Quest’s own infrastructure, ensuring that patient data never leaves the company’s protected environment. The tool is explicitly positioned as an educational resource; it is not a substitute for professional medical advice, diagnosis, or treatment. The partnership with Google Cloud, which began in March 2025, brings advanced generative‑AI capabilities to Quest’s patient‑centric services while maintaining strict privacy controls.
The launch dovetails with Quest’s broader direct‑to‑consumer strategy, which generated nearly $100 million in revenue in 2024 and is growing at 30‑40% annually. By giving patients a clearer understanding of their lab results, Quest aims to increase engagement, improve health outcomes, and create a new revenue stream that is less dependent on traditional reimbursement models. The AI Companion is expected to drive additional traffic to QuestHealth.com, the company’s consumer‑facing platform that generated about $45 million in 2023.
"Patients often tell us they want help simplifying and understanding their test results and what the results communicate about their health," said Nicole Antonson, vice president of digital solutions and interoperability. "Now, Quest AI Companion builds on this history and empowers patients to analyze their results and spot trends they can discuss with their healthcare provider, for smarter and simpler testing that illuminates a path to better health." "People want to understand their lab data, but not everyone feels comfortable uploading their health data to public AI platforms. Quest AI Companion empowers people to access the benefits of gen AI from a healthcare services provider they already know and trust to manage their most personal lab information," added Yuri Fesko, M.D., senior vice president and chief medical officer.
The AI Companion’s introduction signals Quest’s commitment to digital innovation and consumer empowerment. By keeping the tool within its own secure ecosystem, the company addresses patient privacy concerns while leveraging cutting‑edge AI to enhance the value of its lab services. The move also positions Quest to capture a larger share of the growing direct‑to‑consumer diagnostics market, where patients increasingly seek immediate, actionable insights from their health data.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.